These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34979547)

  • 1. Two Cases of Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections Caused by the Omicron Variant (B.1.1.529 Lineage) in International Travelers to Japan.
    Maruki T; Iwamoto N; Kanda K; Okumura N; Yamada G; Ishikane M; Ujiie M; Saito M; Fujimoto T; Kageyama T; Saito T; Saito S; Suzuki T; Ohmagari N
    Clin Infect Dis; 2022 Aug; 75(1):e354-e356. PubMed ID: 34979547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan.
    Okumura N; Tsuzuki S; Saito S; Hattori SI; Takeuchi JS; Saito T; Ujiie M; Hojo M; Iwamoto N; Sugiura W; Mitsuya H; Ohmagari N
    J Infect Chemother; 2022 Sep; 28(9):1340-1343. PubMed ID: 35644734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the Omicron variant of SARS-CoV-2 in international travelers returning to Venezuela.
    Jaspe RC; Sulbaran Y; Loureiro CL; Moros ZC; Marulanda E; Bracho F; Ramírez NA; Canonico Y; D'Angelo P; Rodríguez L; Castro J; Liprandi F; Rangel HR; Pujol FH
    Travel Med Infect Dis; 2022; 48():102326. PubMed ID: 35395405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus-2 Omicron Variant of Concern.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 May; 94(5):2160-2166. PubMed ID: 35050521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Paz M; Aldunate F; Arce R; Ferreiro I; Cristina J
    Virus Res; 2022 Jun; 314():198753. PubMed ID: 35331836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The First Case of a Child Infected with SARS-CoV-2 Omicron Variant in Japan, December 2021.
    Horigome A; Yamanaka J; Takasago S; Iwamoto N; Saito T; Shichino H
    Jpn J Infect Dis; 2023 Jan; 76(1):69-71. PubMed ID: 36047182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas.
    Christensen PA; Olsen RJ; Long SW; Snehal R; Davis JJ; Ojeda Saavedra M; Reppond K; Shyer MN; Cambric J; Gadd R; Thakur RM; Batajoo A; Mangham R; Pena S; Trinh T; Kinskey JC; Williams G; Olson R; Gollihar J; Musser JM
    Am J Pathol; 2022 Apr; 192(4):642-652. PubMed ID: 35123975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis.
    Aoki A; Mori Y; Okamoto Y; Jinno H
    Biol Pharm Bull; 2022 Apr; 45(4):394-396. PubMed ID: 35067489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
    Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
    Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
    Ren B; Liao BY; Wang JN; Peng X; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panorama of Breakthrough Infection Caused by SARS-CoV-2: A Review.
    Fan Q; Nie Z; Xie S
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
    Rahmani S; Rezaei N
    Acta Biomed; 2022 May; 93(2):e2022097. PubMed ID: 35546004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic evidence of co-identification with Omicron and Delta SARS-CoV-2 variants: a report of two cases.
    Wawina-Bokalanga T; Logist AS; Sinnesael R; Van Holm B; Delforge ML; Struyven P; Cuypers L; André E; Baele G; Maes P
    Int J Infect Dis; 2022 Sep; 122():212-214. PubMed ID: 35605952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
    Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
    Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M; Kanno T; Saito S; Miyamoto S; Ainai A; Tobiume M; Arashiro T; Fujimoto T; Saito T; Yamato M; Suzuki T; Ohmagari N
    Emerg Infect Dis; 2022 May; 28(5):998-1001. PubMed ID: 35290176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.